Jorge Pagola Pérez Blanca My daily work involves clinical practice, teaching, and research. As a physician, I am a vascular neurologist, providing hospital care and on-call services. I specialize in cardioembolic stroke, both in its diagnosis and treatment. As an educator, I coordinate training in focused ultrasound at the national and international levels. My field of research has been the diagnosis and treatment of ischemic stroke. In my Doctoral Thesis in 2010 I defended the influence of advanced fibrinolytic treatment in the worst-prognosis stroke, basilar thrombosis. Later, already at the time of the development of thrombectomy, we published the usefulness of stent retrievers and in recent years I collaborated in the achievement and improvement of this type of treatment that has demonstrated the impact on clinical improvement and a reduction in mortality. In recent years, my field of research has focused on the diagnosis of the cause of stroke with advanced techniques, because in my opinion, it did not make sense to continue performing endovascular treatment and not knowing the origin of the stroke in up to 30% of cases. We have developed new diagnostic techniques that have been adapted to our daily clinical practice (wearable Holter, focused echocardiography, analysis of atrial deformability). In recent years, our group has continued to innovate in the detection of atrial fibrillation, now with smart bracelets that empower the patient in their self-care. In this effort to improve diagnosis, we have created a protocol for analyzing the thrombus extracted from acute cerebral occlusion. We have created lines of research to determine, through histological, immunohistochemical and proteomic analysis of the thrombus, the cause of the stroke and the response to both lytic drugs and endovascular therapy. Finally, we have created a new innovative line, cytometry of the thrombus extracted in thrombectomy of acute stroke. A technique that is faster and less expensive than the usual histological analysis and that has been shown to be able to identify thrombi of cardioembolic origin and those most resistant to recanalization. Instituciones de las que forman parte Investigador/a principal Investigación en Ictus Vall Hebron Institut de Recerca Ictus y Hemodinámica Cerebral Hospital General LinkedIn Twitter Orcid Email Jorge Pagola Pérez Blanca LinkedIn Twitter Orcid Email Instituciones de las que forman parte Investigador/a principal Investigación en Ictus Vall Hebron Institut de Recerca Ictus y Hemodinámica Cerebral Hospital General My daily work involves clinical practice, teaching, and research. As a physician, I am a vascular neurologist, providing hospital care and on-call services. I specialize in cardioembolic stroke, both in its diagnosis and treatment. As an educator, I coordinate training in focused ultrasound at the national and international levels. My field of research has been the diagnosis and treatment of ischemic stroke. In my Doctoral Thesis in 2010 I defended the influence of advanced fibrinolytic treatment in the worst-prognosis stroke, basilar thrombosis. Later, already at the time of the development of thrombectomy, we published the usefulness of stent retrievers and in recent years I collaborated in the achievement and improvement of this type of treatment that has demonstrated the impact on clinical improvement and a reduction in mortality. In recent years, my field of research has focused on the diagnosis of the cause of stroke with advanced techniques, because in my opinion, it did not make sense to continue performing endovascular treatment and not knowing the origin of the stroke in up to 30% of cases. We have developed new diagnostic techniques that have been adapted to our daily clinical practice (wearable Holter, focused echocardiography, analysis of atrial deformability). In recent years, our group has continued to innovate in the detection of atrial fibrillation, now with smart bracelets that empower the patient in their self-care. In this effort to improve diagnosis, we have created a protocol for analyzing the thrombus extracted from acute cerebral occlusion. We have created lines of research to determine, through histological, immunohistochemical and proteomic analysis of the thrombus, the cause of the stroke and the response to both lytic drugs and endovascular therapy. Finally, we have created a new innovative line, cytometry of the thrombus extracted in thrombectomy of acute stroke. A technique that is faster and less expensive than the usual histological analysis and that has been shown to be able to identify thrombi of cardioembolic origin and those most resistant to recanalization.
Proyectos ESCALA DE RIESGO DE ICTUS EN PACIENTES CON FIBRILACIÓN AURICULAR Y ANTICOAGULANTES ORALES DIRECTOS IP: Jorge Pagola Pérez Blanca Colaboradores: José Alvarez Sabin, Noelia Rodríguez Villatoro, Jaume Francisco Pascual, Hug Cuellar Calabria, ESCALA DE RIESGO DE ICTUS EN PACIENTES CON FIBRILACIÓN AURICULAR Y ANTICOAGULANTES ORALES DIRECTOS, Claudia Meza Burgos, Federica Rizzo Entidad financiadora: Instituto de Salud Carlos III Financiación: 61250 Referencia: PI24/00333 Duración: 01/01/2025 - 31/12/2027 NexTOLL: A Phase IIb Clinical Trial to evaluate the neuroprotective effect of ApTOLL in stroke patients IP: Marc Ribó Jacobi Colaboradores: Marta Aurora Rubiera del Fueyo, Jorge Pagola Pérez Blanca, Carlos Molina Cateriano, Mª Ángeles Muchada López Entidad financiadora: Ministerio Ciencia, Innovación y Universidades Financiación: 498435 Referencia: CPP2022-009778 Duración: 09/03/2023 - 03/12/2026 NexTOLL: A Phase IIb Clinical Trial to evaluate the neuroprotective effect of ApTOLL in stroke patients IP: Marc Ribó Jacobi Colaboradores: Marta Aurora Rubiera del Fueyo, Jorge Pagola Pérez Blanca, Carlos Molina Cateriano, Mª Ángeles Muchada López Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN Financiación: 498435 Referencia: CPP2022-009778 Duración: 09/03/2023 - 08/03/2026 VALIDACIÓN DIAGNÓSTICA DE UNA PULSERA INTELIGENTE PARA LA DETECCIÓN DE FIBRIL IP: Jorge Pagola Pérez Blanca Colaboradores: Nuria Rivas Gandara, José Alvarez Sabin, Jaume Francisco Pascual Entidad financiadora: Instituto de Salud Carlos III Financiación: 85910 Referencia: PI20/01210 Duración: 01/01/2021 - 30/06/2025 Paginación Página actual 1 Página 2 Página 3 Siguiente página › Última página »
